vemurafenib in patients with braf600 mutation–positive metastatic melanoma
Published 8 years ago • 1.9K plays • Length 6:22Download video MP4
Download video MP3
Similar videos
-
4:05
vemurafenib and cobimetinib in patients with braf-mutated melanoma
-
7:10
columbus: encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with braf-m...
-
3:40
brim8: vemurafenib in high risk melanoma patients
-
3:33
cobimetinib plus vemurafenib for advanced braf-mutated melanoma
-
2:04
combination therapies with vemurafenib in braf v600e–mutant cancers
-
4:49
vemurafenib for high risk melanoma patients
-
4:15
vemurafenib in combination with the mek inhibitor, gdc-0973 in brafv600 mutation pos melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
7:19
melanoma brain metastases and vemurafenib: need for further investigation
-
3:08
os rates and prognostic categories for braf-mutated melanoma when treated with combination therapy
-
5:02
prognostic value of brafv600 mutations in stage 3 cutaneous melanoma patients
-
0:42
how to treat braf positive patients with metastatic melanoma? | onc brothers #2023 #oncology #cancer
-
5:13
dabrafenib plus trametinib improves melanoma patients’ survival
-
2:58
role of braf mutation in the treatment for melanoma
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
22:44
braf targeted therapy - melanoma education symposium, peter boasberg md
-
7:05
improved response rate and survival with dabrafenib plus trametinib vs vemurafenib alone in melanoma
-
2:10
about mutations in advanced (unresectable or metastatic) melanoma
-
2:14
zelboraf (vemurafenib)- metastatic melanoma